Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP): 2 pipeline candidates · ~1 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
0.7 months
0% dilution
Lead: Phase 1/Phase 2
2 candidates
N/A
0 buys · 2 sells (180d)
A transparent, data-derived signal for Indaptus Therapeutics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$479.6M
Cash
$1.5M
Quarterly Burn
$7.0M
Runway
0.7 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| decoy20 | Phase 1/Phase 2 |
| tislelizumab | Phase 1/Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
3
Total value held
$125K
| Holder | Shares | Value |
|---|---|---|
| citadel advisors llc | 39,018 | $71K |
| geode capital management, llc | 27,007 | $49K |
| morgan stanley | 2,697 | $5K |
Frequently asked questions
How many drug candidates are in Indaptus Therapeutics, Inc.'s pipeline?
Indaptus Therapeutics, Inc. (INDP) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Indaptus Therapeutics, Inc.'s lead drug candidate?
Indaptus Therapeutics, Inc.'s most advanced tracked candidate is decoy20 (Phase 1/Phase 2) for Solid Tumor, Adult.
What is Indaptus Therapeutics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Indaptus Therapeutics, Inc. has approximately 0.7 months of cash runway.
What is Indaptus Therapeutics, Inc.'s market capitalization?
Indaptus Therapeutics, Inc.'s market capitalization is approximately $479.6M.
Who is the CEO of Indaptus Therapeutics, Inc.?
Mr. Junyi Dai is the chief executive officer of Indaptus Therapeutics, Inc. (INDP).
Get the full picture on Indaptus Therapeutics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.